Who backs Pathalys Pharma?
12 investors| Investor | Type |
|---|---|
| KB Investment | Venture capital |
| OrbiMed | Growth equity |
| Samsara BioCapital | Venture capital |
| The Carlyle Group | PE / buyout |
| Japan Post Investment | PE / buyout |
| Marshall Wace | Hedge fund |
| Abingworth | — |
| Catalys Pacific | — |
| DaVita Venture Group | — |
| JPMorgan Life Sciences Private Capital | — |
| + 2 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Pathalys Pharma investors
12 investors are on record for Pathalys Pharma, including KB Investment, OrbiMed, Samsara BioCapital and The Carlyle Group. By type, the record holds 2 venture capital firms, 2 private equity firms and 1 hedge fund.
Free account
More of Pathalys Pharma with a free account
- ·The complete investor list: 12 names
- ·Watch Pathalys Pharma: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 12 firms already write checks for companies like Pathalys Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View